ORA

Ormat Technologies, Inc. NYSE

Utilities ·Renewable Utilities ·US · ormat.com

$115.34

Pre-mkt $119.00 +3.17%

Mkt Cap $7.1B

52w Low $70.42 72.3% of range 52w High $132.58

50d MA $111.08 200d MA $106.99

P/E (TTM) 55.6x

EV/EBITDA 17.3x

P/B 2.6x

Debt/Equity 1.1x

ROE 4.9%

P/FCF -23.6x

RSI (14) —

ATR (14) —

Beta 0.80

50d MA $111.08

200d MA $106.99

Avg Volume 876.7K

About

Ormat Technologies, Inc. engages in the geothermal and recovered energy power business in the United States, Indonesia, Kenya, Turkey, Chile, Guadeloupe, Guatemala, Ethiopia, New Zealand, Honduras, and internationally. It operates through three segments: Electricity, Product, and Energy Storage. The Electricity segment develops, builds, owns, and operates geothermal, solar photovoltaic, and recove…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Feb 25, 2026	AMC	0.67	0.67	+0.0%	117.06	-1.4%	-9.0%	-11.4%	-8.5%	-9.4%	-7.9%	—
Nov 3, 2025	AMC	0.37	0.41	+10.8%	107.82	+4.1%	+0.8%	+5.6%	+6.4%	+5.2%	+6.2%	—
Aug 6, 2025	AMC	0.37	0.48	+29.7%	85.20	-0.2%	+2.5%	+1.7%	+2.8%	+4.3%	+5.0%	—
May 7, 2025	AMC	0.58	0.68	+17.2%	72.31	+5.4%	+2.5%	+3.5%	+2.4%	+1.5%	+1.0%	—
Feb 26, 2025	AMC	0.47	0.72	+53.2%	68.29	+3.6%	+1.0%	+2.3%	+0.6%	+1.9%	+1.7%	—
Nov 6, 2024	AMC	0.31	0.42	+35.5%	81.92	-0.4%	+1.4%	+1.5%	+2.3%	-2.9%	-3.3%	—
Aug 6, 2024	AMC	0.36	0.40	+11.1%	73.94	+3.0%	-2.0%	-1.0%	-1.9%	-3.0%	-1.7%	—
May 8, 2024	AMC	0.63	0.64	+1.6%	68.49	+3.1%	+0.6%	+2.6%	+3.2%	+6.9%	+6.7%	—
Feb 21, 2024	AMC	0.59	0.59	+0.0%	67.22	-3.6%	-4.8%	-4.2%	-5.0%	-3.3%	-4.1%	—
Nov 8, 2023	AMC	0.35	0.59	+68.6%	62.42	-1.8%	+0.2%	-2.6%	-5.5%	+2.9%	+4.3%	—
Aug 2, 2023	AMC	0.34	0.40	+17.6%	79.07	+1.9%	-4.1%	-2.6%	-0.3%	-1.9%	-2.5%	—
May 9, 2023	AMC	0.50	0.51	+2.0%	85.21	+0.3%	-2.1%	-1.9%	-1.6%	-1.2%	-2.0%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Apr 16	JP Morgan	Maintains	Neutral → Neutral	—	$113.81	$113.44	-0.3%	-1.1%	-0.7%	-1.9%	-5.0%	-6.0%
Mar 3	UBS	Maintains	Buy → Buy	—	$107.15	$105.16	-1.9%	-1.0%	+0.6%	+0.6%	+1.6%	+2.5%
Mar 2	Barclays	Maintains	Overweight → Overweight	—	$103.70	$104.59	+0.9%	+3.3%	+2.3%	+3.9%	+4.0%	+5.0%
Feb 27	Baird	Maintains	Outperform → Outperform	—	$106.47	$105.58	-0.8%	-2.6%	+0.6%	-0.4%	+1.2%	+1.3%
Feb 18	Citigroup	Maintains	Neutral → Neutral	—	$124.22	$123.07	-0.9%	-2.6%	-3.4%	-6.7%	-7.3%	-6.7%
Feb 13	Jefferies	Downgrade	Buy → Hold	—	$120.40	$116.26	-3.4%	-1.8%	+3.2%	+0.5%	-0.3%	-3.7%
Jan 27	Oppenheimer	Maintains	Outperform → Outperform	—	$123.59	$124.05	+0.4%	+2.1%	+3.5%	+3.6%	+1.1%	+1.8%
Jan 15	Barclays	Maintains	Overweight → Overweight	—	$119.72	$119.79	+0.1%	-3.2%	-1.5%	-1.7%	+1.9%	+2.7%
Jan 9	TD Cowen	Upgrade	Hold → Buy	—	$114.02	$115.97	+1.7%	+1.2%	+4.4%	+5.6%	+5.0%	+1.7%
Dec 18	Piper Sandler	Maintains	Overweight → Overweight	—	$108.84	$111.35	+2.3%	+1.4%	+1.8%	+3.0%	+4.1%	+5.1%
Nov 7	UBS	Maintains	Buy → Buy	—	$114.75	$113.30	-1.3%	-1.1%	-0.2%	-1.7%	-3.0%	-6.0%
Nov 7	Barclays	Maintains	Overweight → Overweight	—	$114.75	$113.30	-1.3%	-1.1%	-0.2%	-1.7%	-3.0%	-6.0%
Nov 5	JP Morgan	Maintains	Neutral → Neutral	—	$108.65	$110.62	+1.8%	+4.8%	+5.6%	+4.4%	+5.4%	+3.8%
Nov 5	Roth Capital	Maintains	Buy → Buy	—	$108.65	$110.62	+1.8%	+4.8%	+5.6%	+4.4%	+5.4%	+3.8%
Nov 5	TD Cowen	Maintains	Hold → Hold	—	$108.65	$110.62	+1.8%	+4.8%	+5.6%	+4.4%	+5.4%	+3.8%
Oct 16	JP Morgan	Maintains	Neutral → Neutral	—	$109.21	$109.88	+0.6%	+1.1%	-0.5%	+0.6%	-3.4%	-4.7%
Oct 7	Jefferies	Maintains	Buy → Buy	—	$104.13	$103.97	-0.2%	+0.7%	+2.7%	+2.4%	-0.2%	+3.0%
Sep 17	Piper Sandler	Upgrade	Neutral → Overweight	—	$91.05	$92.37	+1.4%	+1.6%	+3.2%	+1.6%	+1.8%	+3.0%
Aug 19	Piper Sandler	Maintains	Neutral → Neutral	—	$92.02	$91.75	-0.3%	+0.8%	+0.3%	+0.6%	+3.1%	+0.7%
Aug 8	Barclays	Maintains	Overweight → Overweight	—	$87.33	$87.61	+0.3%	-0.7%	+0.3%	+1.8%	+2.5%	+1.2%
Aug 5	Roth Capital	Maintains	Buy → Buy	—	$88.38	$85.60	-3.1%	-3.6%	-3.6%	-1.2%	-1.9%	-0.9%
Jul 30	Baird	Upgrade	Neutral → Outperform	—	$88.15	$89.03	+1.0%	+1.5%	+1.4%	+0.6%	+0.3%	-3.3%
Jul 24	UBS	Maintains	Buy → Buy	—	$90.41	$88.97	-1.6%	-1.5%	-1.0%	-2.2%	-2.5%	-1.1%
Jul 22	JP Morgan	Maintains	Neutral → Neutral	—	$89.60	$89.79	+0.2%	+0.9%	+0.9%	-0.6%	-0.1%	-1.4%
Jul 10	Barclays	Maintains	Overweight → Overweight	—	$88.14	$87.02	-1.3%	+0.5%	-0.3%	-0.7%	-1.6%	-0.8%
Jun 6	Barclays	Upgrade	Equal Weight → Overweight	—	$75.12	$77.00	+2.5%	+3.5%	+3.6%	+5.2%	+6.1%	+5.4%
May 8	Barclays	Maintains	Equal Weight → Equal Weight	—	$72.31	$76.22	+5.4%	+2.5%	+3.5%	+2.4%	+1.5%	+1.0%
Mar 25	Jefferies	Maintains	Buy → Buy	—	$71.15	$71.56	+0.6%	+0.1%	-1.9%	-1.5%	-0.8%	-0.5%
Feb 28	JP Morgan	Maintains	Neutral → Neutral	—	$68.94	$69.58	+0.9%	+1.3%	-0.3%	+1.0%	+0.8%	+0.6%
Feb 20	Jefferies	Upgrade	Hold → Buy	—	$66.03	$67.69	+2.5%	+4.9%	+4.2%	+3.9%	+3.8%	+3.4%
Nov 8	Roth MKM	Maintains	Buy → Buy	—	$83.05	$82.80	-0.3%	+0.1%	+1.0%	-4.3%	-4.6%	-4.3%
Nov 8	Oppenheimer	Maintains	Outperform → Outperform	—	$83.05	$82.80	-0.3%	+0.1%	+1.0%	-4.3%	-4.6%	-4.3%
Aug 12	Roth MKM	Maintains	Buy → Buy	—	$72.51	$71.24	-1.8%	-1.1%	+0.3%	+0.3%	+1.6%	+1.7%
Aug 8	Oppenheimer	Maintains	Outperform → Outperform	—	$72.49	$72.96	+0.6%	+1.0%	+0.0%	-1.1%	+0.3%	+0.3%
Jul 16	JP Morgan	Maintains	Neutral → Neutral	—	$72.96	$73.18	+0.3%	+4.2%	+3.4%	+2.9%	+1.3%	+3.1%
Jun 21	Oppenheimer	Maintains	Outperform → Outperform	—	$70.90	$70.87	-0.0%	+2.0%	+3.0%	+3.2%	+3.0%	+4.5%
May 14	UBS	Maintains	Buy → Buy	—	$70.65	$71.79	+1.6%	+3.6%	+3.5%	+2.6%	+2.6%	+1.0%
May 13	Barclays	Maintains	Equal Weight → Equal Weight	—	$70.29	$70.57	+0.4%	+0.5%	+4.1%	+4.0%	+3.1%	+3.1%
May 10	TD Cowen	Maintains	Hold → Hold	—	$68.93	$69.42	+0.7%	+2.0%	+2.5%	+6.2%	+6.1%	+5.2%
Feb 5	Barclays	Maintains	Equal Weight → Equal Weight	—	$65.55	$64.42	-1.7%	-2.0%	+0.0%	-0.1%	-2.3%	-0.7%
Jan 19	Oppenheimer	Maintains	Outperform → Outperform	—	$66.69	$66.75	+0.1%	+0.0%	+1.0%	-0.3%	-1.8%	-0.5%
Oct 19	JP Morgan	Maintains	Neutral → Neutral	—	$68.00	$67.79	-0.3%	-1.0%	-2.3%	-4.4%	-5.4%	-6.4%
Oct 12	Oppenheimer	Maintains	Outperform → Outperform	—	$68.87	$67.84	-1.5%	-3.0%	-2.4%	-1.0%	-0.5%	-1.3%
Aug 7	Roth MKM	Upgrade	Neutral → Buy	—	$76.98	$78.56	+2.1%	+2.4%	+0.8%	+0.2%	+0.2%	+0.0%
Jun 27	Oppenheimer	Maintains	Outperform → Outperform	—	$80.61	$80.53	-0.1%	+0.0%	-1.0%	-1.0%	-0.2%	-0.7%
Jun 16	Citigroup	Maintains	Neutral → Neutral	—	$86.44	$87.22	+0.9%	-1.2%	-2.3%	-2.0%	-2.9%	-5.6%
May 22	Barclays	Maintains	Equal Weight → Equal Weight	—	$83.48	$84.12	+0.8%	+1.6%	+1.2%	+2.1%	+0.6%	+1.7%
May 11	Oppenheimer	Maintains	Outperform → Outperform	—	$83.40	$83.73	+0.4%	+0.2%	+0.6%	+1.0%	+0.2%	+1.2%
May 11	Roth MKM	Maintains	Neutral → Neutral	—	$83.40	$83.73	+0.4%	+0.2%	+0.6%	+1.0%	+0.2%	+1.2%
Mar 27	Citigroup	Maintains	Neutral → Neutral	—	$80.98	$82.37	+1.7%	+3.1%	+3.2%	+4.3%	+4.6%	+4.7%

Recent Filings

8-K · 1.01 !! High

Unknown — 8-K 1.01: Material Agreement

ORA has secured non-dilutive debt financing through 2026, providing capital without equity dilution, though investors should monitor repayment capacity given the non-accreting structure.

Mar 23

8-K

Ormat Technologies, Inc. -- 8-K Filing

I cannot provide a meaningful analysis as the filing summary contains only signature blocks and contact information without disclosing the material event triggering the 8-K filing.

Feb 26

8-K · 7.01 ! Medium

Ormat Technologies, Inc. -- 8-K 7.01: Regulation FD Disclosure

Ormat Technologies disclosed material information via press release, which investors should review in Exhibit 99.1 for details on company developments affecting ORA stock.

Feb 17

Data updated apr 26, 2026 5:47pm · Source: massive.com